Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-16 6:04 pm Purchase | 2026-06-09 | 13G | ELOXX PHARMACEUTICALS INC ELOX | Stonepine Capital Management, LLC | 403,228 9.900% | 403,228 (New Position) | Filing History |
| 2026-06-09 4:07 pm Purchase | 2026-06-02 | 13G | SINTX TECHNOLOGIES INC PAR SINT | Stonepine Capital Management, LLC | 619,592 9.900% | 619,592 (New Position) | Filing History |
| 2026-05-15 5:26 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Stonepine Capital Management, LLC | 975,200 3.700% | 602,403 (+161.59%) | Filing History |
| 2026-05-15 5:23 pm Purchase | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management, LLC | 7,594,166 9.990% | 4,323,066 (+132.16%) | Filing History |
| 2026-05-15 5:15 pm Sale | 2026-03-31 | 13G | EDESA BIOTECH INC EDSA | Stonepine Capital Management, LLC | 30,000 0.300% | -663,551 (-95.67%) | Filing History |
| 2026-05-15 5:10 pm Purchase | 2026-03-31 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 159,790 9.900% | 110,963 (+227.26%) | Filing History |
| 2026-05-11 7:05 pm Purchase | 2026-05-04 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Stonepine Capital Management, LLC | 863,277 9.900% | 863,277 (New Position) | Filing History |
| 2026-03-27 6:58 pm Purchase | 2026-03-17 | 13G | CURIS INC PAR $0.01 CRIS | Stonepine Capital Management, LLC | 4,025,992 9.900% | 4,025,992 (New Position) | Filing History |
| 2026-02-13 5:06 pm Sale | 2025-12-31 | 13G | SURROZEN INC SRZN | Stonepine Capital Management, LLC | 316,289 3.600% | -192,398 (-37.82%) | Filing History |
| 2026-02-13 5:02 pm Purchase | 2025-12-31 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 48,827 7.900% | 16,607 (+51.54%) | Filing History |
| 2026-02-13 5:00 pm Sale | 2025-12-31 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Stonepine Capital Management, LLC | 156,179 2.100% | -221,061 (-58.60%) | Filing History |
| 2026-02-02 8:01 pm Purchase | 2026-01-29 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management, LLC | 3,271,100 10.600% | 240,174 (+7.92%) | Filing History |
| 2025-12-22 5:15 pm Purchase | 2025-12-19 | 13G | IN8BIO INC INAB | Stonepine Capital Management, LLC | 1,007,990 9.900% | 1,007,990 (New Position) | Filing History |
| 2025-12-16 4:04 pm Purchase | 2025-12-10 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management, LLC | 3,030,926 9.900% | 3,030,926 (New Position) | Filing History |
| 2025-11-13 4:19 pm Sale | 2025-09-30 | 13G | VERASTEM INC VSTM | Stonepine Capital Management, LLC | 2,670,032 4.300% | -163,301 (-5.76%) | Filing History |
| 2025-11-04 12:19 pm Purchase | 2025-10-29 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 32,220 5.600% | 32,220 (New Position) | Filing History |
| 2025-09-08 5:44 pm Purchase | 2025-09-02 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Stonepine Capital Management, LLC | 377,240 5.200% | 377,240 (New Position) | Filing History |
| 2025-08-13 4:16 pm Purchase | 2025-06-30 | 13G | AYTU BIOPHARMA INC PAR $0. AYTU | Stonepine Capital Management, LLC | 906,063 9.900% | 279,201 (+44.54%) | Filing History |
| 2025-08-13 4:08 pm Purchase | 2025-06-30 | 13G | SURROZEN INC SRZN | Stonepine Capital Management, LLC | 508,687 5.800% | 176,236 (+53.01%) | Filing History |
| 2025-08-06 1:10 pm Purchase | 2025-07-22 | 13G | VERASTEM INC VSTM | Stonepine Capital Management, LLC | 2,833,333 5.000% | 630,000 (+28.59%) | Filing History |